GT Biopharma (GTB-004 Rights)

Business Data, Corporate Office and Headquarter Address

About

GT Biopharma (GTB-004 Rights) is Drug Discovery in United States that focus on treatment business. They cover business area such as treatment, myasthenia gravis, pyridostigmine, gastrointestinal side effect.

Business Type

Drug Discovery

Country

United States

Founded

-

Company Focus

Treatment

Website

-

Corporate Office and Headquarter Office address:

9350 Wilshire Boulevard
Suite 203
Beverly Hills, CA
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

treatmentmyasthenia gravispyridostigminegastrointestinal side effect

* We use standard office opening hours in near GT Biopharma (GTB-004 Rights)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

GT Biopharma (GTB-004 Rights) Frequently Asked Questions

What or who is GT Biopharma (GTB-004 Rights)?

GT Biopharma (GTB-004 Rights) is Drug Discovery business from United States that founded in - ( years old in ), GT Biopharma (GTB-004 Rights) business is focusing on Treatment.

Where is GT Biopharma (GTB-004 Rights) headquarter and corporate office address?

GT Biopharma (GTB-004 Rights) headquarter office and corporate office address is located in 9350 Wilshire Boulevard Suite 203 Beverly Hills, CA United States.

Where is GT Biopharma (GTB-004 Rights) country origins?

GT Biopharma (GTB-004 Rights) was founded in United States.

What is Treatment business focus on?

In , GT Biopharma (GTB-004 Rights) is currently focus on treatment sector.

Treatment Business Interest from Google Trend

Above is snippet of Google Trends for "treatment" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with GT Biopharma (GTB-004 Rights), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.